Skip to main content
    T

    Tenaya Therapeutics Inc (TNYA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.33
    -0.02 (-4.47%)

    Market Cap: $79.59M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Tenaya Therapeutics Inc (TNYA) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Tenaya Therapeutics (TNYA) is expected to report earnings on Mar 4, 2027. In the quarter ended Sep 30, 2026, Tenaya Therapeutics reported EPS of -$0.08, above the -$0.10 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    64%(14/22)
    Avg Surprise
    +0.43%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 4, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.09
    Range-$0.10 - -$0.07
    8 analysts
    Revenue Consensus
    $2.67M
    RangeN/A
    6 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.08
    Range-$0.09 - -$0.07
    3 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.10+16.7%
    60d ago-$0.10+16.7%
    30d ago-$0.10+16.7%
    7d ago-$0.10+16.7%
    Current-$0.08
    Revenue Consensus
    $550.00K
    RangeN/A
    2 analysts

    Next Report

    TNYA has an expected report date of Mar 4, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, TNYA beat 14, missed 7 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2021, when EPS landed 84.94% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.08-$0.10-$0.10 - -$0.09+20.00%BeatN/A40 up, 3 downNov 4, 2026$1.70M
    Jun 30, 2026-$0.09-$0.08-$0.14 - -$0.04-12.50%MissN/A61 up, 0 downAug 5, 2026$1.11M
    Mar 31, 2026-$0.09-$0.09-$0.14 - -$0.050.00%In lineN/A61 up, 0 downMay 6, 2026$225000
    Dec 31, 2025-$0.12-$0.14-$0.17 - -$0.10+12.73%BeatN/A84 up, 0 downMar 11, 2026N/A
    Sep 30, 2025-$0.12-$0.15-$0.18 - -$0.10+20.00%BeatN/A85 up, 0 downNov 10, 2025N/A
    Jun 30, 2025-$0.14-$0.19-$0.26 - -$0.11+26.32%BeatN/A81 up, 3 downAug 6, 2025N/A
    Mar 31, 2025-$0.24-$0.20-$0.31 - -$0.14-20.00%MissN/A63 up, 0 downMay 7, 2025N/A
    Dec 31, 2024-$0.28-$0.31-$0.35 - -$0.28+9.68%BeatN/A81 up, 0 downMar 10, 2025N/A
    Sep 30, 2024-$0.30-$0.37-$0.44 - -$0.33+18.92%BeatN/A80 up, 0 downNov 6, 2024N/A
    Jun 30, 2024-$0.34-$0.39-$0.49 - -$0.28+12.82%BeatN/A90 up, 0 downAug 8, 2024N/A
    Mar 31, 2024-$0.40-$0.42-$0.45 - -$0.40+4.76%BeatN/A70 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$0.40-$0.44-$0.50 - -$0.40+9.09%BeatN/A80 up, 0 downMar 18, 2024$17.66M
    Sep 30, 2023-$0.39-$0.48-$0.57 - -$0.40+18.75%BeatN/A70 up, 0 downNov 8, 2023N/A
    Jun 30, 2023-$0.45-$0.51-$0.54 - -$0.46+11.76%BeatN/A60 up, 0 downAug 9, 2023N/A
    Mar 31, 2023-$0.43-$0.55-$0.72 - -$0.45+21.82%BeatN/A60 up, 0 downMay 10, 2023N/A
    Dec 31, 2022-$0.61-$0.65-$0.78 - -$0.51+6.15%BeatN/A60 up, 0 downMar 8, 2023N/A
    Sep 30, 2022-$0.74-$0.68-$0.75 - -$0.55-8.82%MissN/A60 up, 0 downNov 10, 2022N/A
    Jun 30, 2022-$0.69-$0.74N/A+6.76%BeatN/AN/A0 up, 0 downAug 10, 2022N/A
    Mar 31, 2022-$0.75-$0.64-$0.69 - -$0.57-17.19%MissN/A40 up, 0 downMay 11, 2022N/A
    Dec 31, 2021-$0.63-$0.60-$0.83 - -$0.40-5.00%MissN/A40 up, 0 downMar 23, 2022N/A
    Sep 30, 2021-$0.68-$0.48-$1.36 - -$0.36-41.67%MissN/A41 up, 1 downNov 10, 2021N/A
    Jun 30, 2021-$13.26-$7.17-$13.62 - -$0.73-84.94%MissN/A2N/AJul 30, 2021N/A
    Mar 31, 2021-$0.40N/AN/AN/AN/AN/AN/AN/AJun 2, 2021N/A
    Dec 31, 2020-$11.93N/AN/AN/AN/AN/AN/AN/AMar 31, 2021N/A
    Dec 31, 2019-$10.15N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.62, after -$1.32 the year before. It was -$10.15 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.62N/A
    Dec 31, 2024-$1.32N/A
    Dec 31, 2023-$1.67N/A
    Dec 31, 2022-$2.79N/A
    Dec 31, 2021-$14.97N/A
    Dec 31, 2020-$11.93N/A
    Dec 31, 2019-$10.15N/A

    Frequently Asked Questions About TNYA

    When is Tenaya Therapeutics's next earnings date?

    Tenaya Therapeutics's next earnings report is expected for Mar 4, 2027.

    Did TNYA beat earnings estimates last quarter?

    Yes. Tenaya Therapeutics reported EPS of -$0.08 for the quarter ended Sep 30, 2026, above the -$0.10 estimate, a 20.00% surprise.

    What EPS do analysts expect from TNYA next quarter?

    The consensus EPS estimate for Tenaya Therapeutics for the quarter ending Dec 31, 2026 is -$0.09 from 8 analysts, with estimates from -$0.10 to -$0.07.

    How often does TNYA beat earnings estimates?

    Tenaya Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +7.03%.